The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market.
Similar Posts
Insufflation Unit Recall: Olympus Removes High Flow Insufflation Units
Olympus is removing certain High Flow Insufflation Unit models due to software issues that may lead to overpressure events.eCTD Submission Standards for eCTD v4.0 and Regional M1
A listing of the Implementation Guides, Specifications, and Documentation that support the FDA implementation for eCTD v4.0Scope Health Inc – 695085 – 07/09/2025
Unapproved New Drugs/MisbrandedFood To Live Voluntarily Recalls Organic Moringa Products Because of Possible Health Risk
Brooklyn, NY – Food To Live, of Brooklyn, NY, is recalling its packaged Organic Moringa Leaf Powder (dried Moringa oleifera) and its Organic Supergreens Powder Mix distributed under the Food To Live brand that are in the following sizes:Update on the Safety of Andexxa by AstraZeneca: FDA Safety Communication
Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in patients treated with Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo). Based on available data, the serious risks including the increase in thromboembolicEsophageal pH Monitoring Capsule Recall: Medtronic and Given Imaging Remove Bravo CF Capsule Delivery Devices
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program